Aberrant posttranslational modification, localization and aggregation of tau protein have been linked to the progression of AD and its reproducible spread through synaptically connected regions in the brain suggesting that targeting tau may be efficacious in treating AD. This evidence concerns the gene MAPT and Alzheimer disease.